A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Treating patients with ibezapolstat provided high rates of "sustained" clinical cures, say American ...

As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new ...

Syracuse, NY — Upstate Medical University is looking for 1,000 volunteers — its largest clinical trial to date — to test a ...

A total of 54% of adults in the United States were “not at all” familiar with clostridioides difficile (C. diff), a bacterial infection that causes nearly 30,000 deaths in the US each year, according ...

SEATTLE – Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, and kills up to 30,000. It is a leading cause of ...

A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Rates of C. diff in the UK have increased every year since 2021, reaching 29.5 cases per 100,000 ...